Connect your AI

Annexon ANNX Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

MeiraGTx Holdings plcMGTX

$35K+192%

EyePoint, Inc. EYPT

$297K+2.1%

Vor BiopharmaVOR

——

Nektar TherapeuticsNKTR

——

Janux TherapeuticsJANX

——

Other financials

Income statement

Operating income-$46.1M+19.8%

Net income-$44.1M+18.8%

EPS (diluted)-$0.23+37.8%

Balance sheet

Cash & equivalents$175.2M+80.4%

Total debt$25.4M-10.2%

Total equity$204.5M-16.1%

Total assets$262.9M-13.2%

Cash flow

Operating cash flow-$46.8M+6.5%

CapEx--100%

Free cash flow-$46.8M+6.6%

Valuation

Market cap$868.37M+223%

Enterprise value$718.59M+261%

Returns & leverage

Return on equity-87.6%+42.3pp

Debt / equity0.1×0.0×

Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Annexon’s 10-Q, filed May 8, 2023, on SEC EDGAR. View the filing →

Ask your AI about Annexon's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Annexon's payments of stock issuance costs?: Annexon (ANNX) reported payments of stock issuance costs of $75K in Q1 2023.